Market Cap 90.31M
Revenue (ttm) 266.96M
Net Income (ttm) 28.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 10.68%
Debt to Equity Ratio -0.20
Volume 1,822,400
Avg Vol 1,708,078
Day's Range N/A - N/A
Shares Out 115.93M
Stochastic %K 30%
Beta 1.01
Analysts Strong Sell
Price Target $5.26

Company Profile

Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin 27. It also develops CHS-114, an investigat...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 649 3530
Address:
333 Twin Dolphin Drive, Suite 600, Redwood City, United States
Grandgustav
Grandgustav Mar. 15 at 7:28 PM
$CHRS this looks like good news for us because our ccr8 is dope and beigene’s is shit https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/753549/beigene-terminates-early-stage-solid-tumor-trial-shifting-risk-focus-for-oncology-investors/#:~:text=The%20main%20treatment%20is%20BGB%2DA3055%2C%20an%20experimental,alone%20and%20together%20with%20tislelizumab%2C%20BeiGene's%20approved
1 · Reply
Henry20feb_
Henry20feb_ Mar. 14 at 9:32 AM
2 · Reply
Samishere
Samishere Mar. 13 at 8:24 PM
$CHRS Concur,, charts are fun 🤣😆🤣😆🤣😆 Sam 🤑👇🏽
1 · Reply
biokvint
biokvint Mar. 13 at 6:53 PM
$CHRS Added
0 · Reply
AnalyticalOne
AnalyticalOne Mar. 13 at 5:56 PM
$CHRS Institutional algorithms generally make purchases or sales in 100 lot batches. Individuals generally place larger batch orders. I don't think the observation is a bullish sign at all. This would be especially true given the price action at the time you are observing this. I'm not providing a bullish or bearish sentiment, just sayin'...
1 · Reply
Doubletough
Doubletough Mar. 13 at 5:21 PM
$CHRS Added
0 · Reply
Jack_Nicholson_Truth
Jack_Nicholson_Truth Mar. 13 at 2:05 PM
$CHRS that gap down yesterday was a block short sale to clear out mono traders. This is clearing out all the weak hands before any move up or down. MARCH 13! ASCO DATA if chs-114 hsncc makes it in time COULD BE First catalyst: ~April 21, 2026 (acceptance announcement). Until march 20, we likely pinned to $1.75 unless a big fund buys in as that allotment expires 3/19.
0 · Reply
cdlawton07
cdlawton07 Mar. 13 at 1:45 PM
0 · Reply
calibran_de
calibran_de Mar. 13 at 10:41 AM
$CHRS https://uk.investing.com/news/analyst-ratings/oppenheimer-reiterates-coherus-biosciences-stock-rating-at-outperform-93CH-4550592
0 · Reply
whateverhappenedthere
whateverhappenedthere Mar. 13 at 2:59 AM
$CHRS my broker at Merrill keeps shaming me everytime this dips, Denny please shut him up!
3 · Reply
Latest News on CHRS
Coherus Oncology: A Two-Pronged March With Mid-2026 Implications

Dec 23, 2025, 11:06 AM EST - 2 months ago

Coherus Oncology: A Two-Pronged March With Mid-2026 Implications


Coherus Oncology, Inc. (CHRS) Q3 2025 Earnings Call Transcript

Nov 7, 2025, 5:56 PM EST - 4 months ago

Coherus Oncology, Inc. (CHRS) Q3 2025 Earnings Call Transcript


Coherus Oncology: Five Readouts Or More Possible In 2026

Oct 1, 2025, 10:43 AM EDT - 5 months ago

Coherus Oncology: Five Readouts Or More Possible In 2026


Coherus Oncology: On The Shaping Up

Aug 25, 2025, 4:55 PM EDT - 7 months ago

Coherus Oncology: On The Shaping Up


Coherus Oncology, Inc. (CHRS) Q2 2025 Earnings Call Transcript

Aug 9, 2025, 11:35 AM EDT - 7 months ago

Coherus Oncology, Inc. (CHRS) Q2 2025 Earnings Call Transcript


Coherus BioSciences, Inc. (CHRS) Q1 2025 Earnings Call Transcript

May 12, 2025, 10:46 PM EDT - 10 months ago

Coherus BioSciences, Inc. (CHRS) Q1 2025 Earnings Call Transcript


Coherus to Participate in Upcoming Investor Conferences

May 1, 2025, 5:04 PM EDT - 11 months ago

Coherus to Participate in Upcoming Investor Conferences


Why Is Coherus BioSciences Stock Trading Higher On Tuesday?

Dec 3, 2024, 9:34 AM EST - 1 year ago

Why Is Coherus BioSciences Stock Trading Higher On Tuesday?


Grandgustav
Grandgustav Mar. 15 at 7:28 PM
$CHRS this looks like good news for us because our ccr8 is dope and beigene’s is shit https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/753549/beigene-terminates-early-stage-solid-tumor-trial-shifting-risk-focus-for-oncology-investors/#:~:text=The%20main%20treatment%20is%20BGB%2DA3055%2C%20an%20experimental,alone%20and%20together%20with%20tislelizumab%2C%20BeiGene's%20approved
1 · Reply
Henry20feb_
Henry20feb_ Mar. 14 at 9:32 AM
2 · Reply
Samishere
Samishere Mar. 13 at 8:24 PM
$CHRS Concur,, charts are fun 🤣😆🤣😆🤣😆 Sam 🤑👇🏽
1 · Reply
biokvint
biokvint Mar. 13 at 6:53 PM
$CHRS Added
0 · Reply
AnalyticalOne
AnalyticalOne Mar. 13 at 5:56 PM
$CHRS Institutional algorithms generally make purchases or sales in 100 lot batches. Individuals generally place larger batch orders. I don't think the observation is a bullish sign at all. This would be especially true given the price action at the time you are observing this. I'm not providing a bullish or bearish sentiment, just sayin'...
1 · Reply
Doubletough
Doubletough Mar. 13 at 5:21 PM
$CHRS Added
0 · Reply
Jack_Nicholson_Truth
Jack_Nicholson_Truth Mar. 13 at 2:05 PM
$CHRS that gap down yesterday was a block short sale to clear out mono traders. This is clearing out all the weak hands before any move up or down. MARCH 13! ASCO DATA if chs-114 hsncc makes it in time COULD BE First catalyst: ~April 21, 2026 (acceptance announcement). Until march 20, we likely pinned to $1.75 unless a big fund buys in as that allotment expires 3/19.
0 · Reply
cdlawton07
cdlawton07 Mar. 13 at 1:45 PM
0 · Reply
calibran_de
calibran_de Mar. 13 at 10:41 AM
$CHRS https://uk.investing.com/news/analyst-ratings/oppenheimer-reiterates-coherus-biosciences-stock-rating-at-outperform-93CH-4550592
0 · Reply
whateverhappenedthere
whateverhappenedthere Mar. 13 at 2:59 AM
$CHRS my broker at Merrill keeps shaming me everytime this dips, Denny please shut him up!
3 · Reply
biokvint
biokvint Mar. 12 at 7:27 PM
$CHRS Added
0 · Reply
Cowpokecaleb
Cowpokecaleb Mar. 12 at 6:46 PM
$CHRS I have trouble believe that all of the funds which bought 28M shares last month at $1.75 would do so without a high degree of confidence CHRS was worth at least $.25 more
0 · Reply
Jack_Nicholson_Truth
Jack_Nicholson_Truth Mar. 12 at 6:44 PM
$CHRS I assuming we will see news that the underwriters took the 4.5m allottment at 1.75. It aligns with the run up and down.
0 · Reply
cdlawton07
cdlawton07 Mar. 12 at 4:06 PM
$CHRS low 1.60s seems to be the floor. I'm loaded to the gills with 20k shares now. I keep telling myself I won't buy more but I keep buying more...
2 · Reply
jakethesnakeee
jakethesnakeee Mar. 12 at 2:33 PM
$CHRS Time to add🤷
3 · Reply
NormaJean
NormaJean Mar. 12 at 2:10 PM
$CHRS Sell orders are very small amounts - most 100. Buy orders are big lots in thousands. Intentional MM bring the price down to load up. Time to add!
0 · Reply
neofeudal
neofeudal Mar. 12 at 1:44 PM
$CHRS You still want to beat on him? He predicted a retest, which if you view it more broadly, is a floor confirmation that will sustain the rise. Not everybody is a fake, and not every "bearish" sentiment is without context of a bullish overall trend.
2 · Reply
Tomasini
Tomasini Mar. 11 at 8:20 PM
$CHRS this company does nothing but suck up dhareholder money. pos
1 · Reply
ForsakenOne
ForsakenOne Mar. 11 at 8:01 PM
$CHRS love how the massive blocks just vanish as soon as the market closes. MM’s are master manipulators
1 · Reply
rusi1
rusi1 Mar. 11 at 7:54 PM
$CHRS why this drops today?
1 · Reply
Bli1
Bli1 Mar. 11 at 4:47 PM
$CHRS 50mio burned in 1 q. Aye.
0 · Reply
BigDaddyCapital
BigDaddyCapital Mar. 11 at 4:07 PM
$CHRS following XBI, down 6%
0 · Reply